Cure My Disease

Don't miss your cure!

 Log in / Sign up

Polish study aims to uncover the secrets of successful GERD surgery

NCT ID NCT07711912

Knowledge-focused Sponsor: University of Warmia and Mazury in Olsztyn Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only This study
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 17, 2026 · Last updated Jul 17, 2026

Summary

This observational study follows 200 adults with gastroesophageal reflux disease (GERD) who are scheduled for antireflux surgery in Poland. Researchers collect data on surgical techniques, symptom relief, quality of life, and complications over 12 months. The goal is to identify which patient and procedure factors are linked to the best outcomes in routine practice.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could help identify which patients and surgical approaches lead to the best long-term relief from GERD symptoms.
What could go wrong
As an observational study, it cannot prove cause and effect. Results may not apply outside Poland or beyond the specific surgical practices observed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients with gastroesophageal reflux disease (GERD) undergoing elective antireflux surgery at participating surgical centers across Poland. Consecutive eligible patients meeting the inclusion criteria will be prospectively enrolled. All diagnostic evaluation, surgical treatment, and postoperative follow-up will be performed according to the routine clinical practice of each participating center. The study is observational and does not alter standard patient management. Demographic, clinical, operative, and follow-up data will be collected to evaluate current surgical practice and treatment outcomes after antireflux surgery.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18 years or older * Diagnosis of gastroesophageal reflux disease * Qualification for antireflux surgery according to the routine clinical practice of the participating center * Planned antireflux surgical procedure at a participating center * Ability to provide written informed consent * Willingness to participate in postoperative follow-up Exclusion Criteria: * Age younger than 18 years * Lack of qualification for antireflux surgery * Inability to provide informed consent * Refusal to participate in the study * Inability to complete the planned follow-up assessments * Emergency surgery or surgery performed for an indication other than gastroesophageal reflux disease

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Reflux disease, gastro-esophageal are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastroesophageal reflux disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Reflux disease, gastro-esophageal

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of Warmia and Mazury

    Olsztyn, Warminsko-mazusrkie, 10-045, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.